ABVC BioPharma (ABVC) Financial Statements

Compare

126 Followers

ABVC BioPharma Financial Overview

ABVC BioPharma's market cap is currently $26.97M. The company's EPS TTM is $-0.11; its P/E ratio is -6.26; ABVC BioPharma is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Mar 23	Mar 22
Income Statement
Total Revenue	$ 795.95K	$ 509.59K	$ 152.43K	$ 969.78K	$ 355.80K
Gross Profit	$ 795.95K	$ 508.83K	$ -149.61K	$ 683.37K	$ 350.71K
Operating Income	$ -7.15M	$ -4.71M	$ -6.77M	$ -15.11M	$ -11.71M
EBITDA	$ -6.65M	$ -4.34M	$ -6.33M	$ -15.20M	$ -10.97M
Net Income	$ -7.91M	$ -4.90M	$ -7.79M	$ -16.42M	$ -12.84M
Balance Sheet
Cash & Short-Term Investments	$ 745.83K	$ 928.55K	$ 796.09K	$ 1.47M	$ 5.94M
Total Assets	$ 21.06M	$ 7.54M	$ 7.78M	$ 10.93M	$ 13.70M
Total Debt	$ 3.47M	$ 3.20M	$ 2.77M	$ 3.41M	$ 3.34M
Net Debt	$ 2.79M	$ 2.34M	$ 2.05M	$ 2.02M	$ -2.49M
Total Liabilities	$ 7.76M	$ 6.82M	$ 6.53M	$ 6.34M	$ 4.83M
Stockholders' Equity	$ 11.11M	$ 1.23M	$ 1.55M	$ 4.45M	$ 8.84M
Cash Flow
Free Cash Flow	$ -2.99M	$ -1.81M	$ -4.21M	$ -7.52M	$ -7.62M
Operating Cash Flow	$ -2.99M	$ -1.81M	$ -4.19M	$ -7.40M	$ -7.60M
Investing Cash Flow	$ -1.21M	$ 0.00	$ -360.19K	$ -1.72M	$ -805.97K
Financing Cash Flow	$ 4.64M	$ 1.98M	$ 3.87M	$ 4.01M	$ 10.00M

Currency in USD

ABVC BioPharma Earnings and Revenue History

Income Statement >

ABVC BioPharma Debt to Assets

Balance Sheet >

ABVC BioPharma Cash Flow

Cash Flow >

ABVC BioPharma Forecast EPS vs Actual EPS

Earnings >